Spectrum Pharmaceuticals Inc. | Key People and Executives
Stuart Mitchell Krassner
Chairman
Joseph W. Turgeon
President, Chief Executive Officer & Director
Bernice R. Welles
Director
William L. Ashton
Director
Anthony E. Maida
Independent Non-Executive Director
Raymond Wayne Cohen
Independent Non-Executive Director
Dolatrai Vyas
Independent Non-Executive Director
Gilles R. Gagnon
Independent Non-Executive Director
Stuart Mitchell Krassner
Chairman
Joseph W. Turgeon
President, Chief Executive Officer & Director
Thomas J. Riga
Executive VP, Chief Operating & Commercial Officer
Kurt A. Gustafson
Chief Financial Officer & Executive Vice President
Guru Reddy
Vice President-Preclinical Research & Development
Zane Yang
Senior Vice President-Clinical Development
Michael A. Grabow
Senior VP-Corporate Strategy & Operations
Bimal R. Shah
Vice President-Corporate & Business Development
Pramod K. Gupta
Senior Vice President-Pharmaceutical Operations
Bernice R. Welles
Director
William L. Ashton
Director
Lisa A. Croissant
Vice President-Sales
Shiv S. Kapoor
VP-Strategic Planning & Investor Relations
Keith M. McGahan
Chief Legal Officer & Senior Vice President
Anthony E. Maida
Independent Non-Executive Director
Raymond Wayne Cohen
Independent Non-Executive Director
Dolatrai Vyas
Independent Non-Executive Director
Gilles R. Gagnon
Independent Non-Executive Director
| Address |
11500 South Eastern Avenue
Henderson Nevada 89052
United States
|
|
Employees
|
- |
| Website |
http://www.sppirx.com |
| Updated |
07/08/2019 |
| Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV. |
